Last updated June 26th 2017
June 20, 2017 | Israeli medical marijuana startup iCAN has announced a joint venture with Australian company LeafCann Research and Advisory. The new venture will take advantage of Israel’s leadership position in the research and development of medical marijuana, in combination with Australia’s lax regulations. Founded in 2015, iCAN is a leading Israeli developer of cannabis-based formulations, clinical trials and cannabis testing. The firm is headed by Saul Kaye.